Telemedicine in Drug Hypersensitivity
- PMID: 35469621
- DOI: 10.1016/j.iac.2021.12.007
Telemedicine in Drug Hypersensitivity
Abstract
This review focuses on the current applications of telemedicine for drug hypersensitivity reactions. Telemedicine holds promise as a tool to risk-stratify patients with drug hypersensitivity, for both evaluation of penicillin allergies and severe cutaneous adverse reactions. Although telemedicine may not fully replace in-person assessment owing to the need for testing, challenges, and in-person physical examination or skin biopsy, it may allow for risk stratification whereby some in-person visits may not be necessary. Electronic consults have also emerged along with telemedicine as a tool for drug allergy evaluations.
Keywords: Adverse drug reaction; Drug allergy; Electronic consult; Penicillin allergy; Severe cutaneous adverse reaction; Telehealth; Telemedicine.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure D. Wells: No relevant disclosures. K. DeNiro: No relevant disclosures. A. Ramsey: Speakers Bureau for Sanofi/Regeneron and GlaxoSmithKline (not relevant for article).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
